Elucidation of lipoprotein particles structure by proteomic analysis

References

• Redgrave TG. Chylomicron metabolism. Biochem. Soc. Trans.32(Pt 1), 79–82 (2004).
   PubMed Web of Science ®Google Scholar
• Hussain MM, Shi J, Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J. Lipid Res.44(1), 22–32 (2003).
   PubMed Web of Science ®Google Scholar
• Sharp D, Blinderman L, Combs KA et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature365(6441), 65–69 (1993).
   PubMed Web of Science ®Google Scholar
• Cockcroft S. ARF-regulated phospholipase D: a potential role in membrane traffic. Chem. Phys. Lipids,80(1–2), 59–80 (1996).
   PubMedGoogle Scholar
• Gibbons GF, Wiggins D, Brown AM, Hebbachi AM. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans.32(Pt 1), 59–64 (2004).
   PubMedGoogle Scholar
• Pease RJ, Leiper JM. Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion. Curr. Opin. Lipidol.7(3), 132–138 (1996).
   PubMed Web of Science ®Google Scholar
• Ardern HA, Benson GM, Suckling KE et al. Apolipoprotein B overproduction by the perfused liver of the St.Thomas’ mixed hyperlipidemic (SMHL) rabbit. J. Lipid Res.40(12), 2234–2243 (1999).
   PubMedGoogle Scholar
• Field FJ, Mathur SN. b-sitosterol: esterification by intestinal acylcoenzyme A: cholesterol acyltransferase (ACAT) and its effect on cholesterol esterification. J. Lipid Res.24(4), 409–417 (1983).
   PubMed Web of Science ®Google Scholar
• Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res.96(12), 1221–1232 (2005).
   PubMed Web of Science ®Google Scholar
• Williamson R, Lee D, Hagaman J, Maeda N. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl Acad. Sci. USA89(15), 7134–7138 (1992).
   PubMed Web of Science ®Google Scholar
• Schaefer EJ, Heaton WH, Wetzel MG, Brewer HB Jr. Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis2(1), 16–26 (1982).
   PubMedGoogle Scholar
• Weng W, Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc. Natl Acad. Sci. USA93(25), 14788–14794 (1996).
   PubMedGoogle Scholar
• Rader DJ. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest.116(12), 3090–3100 (2006).
   PubMed Web of Science ®Google Scholar
• McNeish J, Aiello RJ, Guyot D et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl Acad. Sci. USA97(8), 4245–4250 (2000).
   PubMed Web of Science ®Google Scholar
• Timmins JM, Lee JY, Boudyguina E et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest.115(5), 1333–1342 (2005).
   PubMed Web of Science ®Google Scholar
• Brunham LR, Kruit JK, Iqbal J et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.J. Clin. Invest.116(4), 1052–1062 (2006).
   PubMed Web of Science ®Google Scholar
• Wang N, Ranalletta M, Matsuura F, Peng F, Tall AR. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler. Thromb. Vasc. Biol.26(6), 1310–1316 (2006).
   PubMed Web of Science ®Google Scholar
• Kim WS, Rahmanto AS, Kamili A et al. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-β peptide generation. J. Biol. Chem.282(5), 2851–2861 (2007).
   PubMed Web of Science ®Google Scholar
• Kuivenhoven JA, Pritchard H, Hill J et al. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res.38(2), 191–205 (1997).
   PubMed Web of Science ®Google Scholar
• Ng DS. Insight into the role of LCAT from mouse models. Rev. Endocr. Metab. Disord.5(4), 311–318 (2004).
   PubMed Web of Science ®Google Scholar
• Rader DJ, Ikewaki K, Duverger N et al. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. J. Clin. Invest.93(1), 321–330 (1994).
   PubMed Web of Science ®Google Scholar
• McLean JW, Tomlinson JE, Kuang WJ et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature330(6144), 132–137 (1987).
   PubMed Web of Science ®Google Scholar
• Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum. Mol. Genet.2(7), 933–940 (1993).
   PubMed Web of Science ®Google Scholar
• Spence JD. Lipoprotein(a): involved in events, but not burden of atherosclerotic disease? Stroke37(6), 1350–1351 (2006).
   PubMedGoogle Scholar
• Catapano AL, Kinnunen PK, Breckenridge WC et al. Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. Biochem. Biophys. Res. Commun.89(3), 951–957 (1979).
   PubMed Web of Science ®Google Scholar
• Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med.80(12), 753–769 (2002).
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell Biol.1, 1–39 (1985).
   PubMedGoogle Scholar
• Perret B, Mabile L, Martinez L et al. Hepatic lipase: structure/function relationship, synthesis, and regulation. J. Lipid Res.43(8), 1163–1169 (2002).
   PubMed Web of Science ®Google Scholar
• Krieger M. Charting the fate of the “good cholesterol”: identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem.68, 523–558 (1999).
   PubMed Web of Science ®Google Scholar
• Klerkx AH, El Harchaoui K, van der Steeg WA et al. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. Arterioscler. Thromb. Vasc. Biol.26(4), 706–715 (2006).
   PubMed Web of Science ®Google Scholar
• Kozarsky KF, Donahee MH, Rigotti A et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature387(6631), 414–417 (1997).
   PubMed Web of Science ®Google Scholar
• Rigotti A, Trigatti BL, Penman M et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl Acad. Sci. USA94(23), 12610–12615 (1997).
   PubMed Web of Science ®Google Scholar
• Brundert M, Ewert A, Heeren J et al. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler. Thromb. Vasc. Biol.25(1), 143–148 (2005).
   PubMed Web of Science ®Google Scholar
• Silver DL, Wang N, Xiao X, Tall AR. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J. Biol. Chem.276(27), 25287–25293 (2001).
   PubMed Web of Science ®Google Scholar
• Agellon LB, Walsh A, Hayek T et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem.266(17), 10796–10801 (1991).
   PubMed Web of Science ®Google Scholar
• Brown ML, Inazu A, Hesler CB et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature342(6248), 448–451 (1989).
   PubMed Web of Science ®Google Scholar
• Inazu A, Brown ML, Hesler CB et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med.323(18), 1234–1238 (1990).
   PubMed Web of Science ®Google Scholar
• Russell DW. Cholesterol biosynthesis and metabolism. Cardiovasc. Drugs Ther.6(2), 103–110 (1992).
   PubMed Web of Science ®Google Scholar
• Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu. Rev. Nutr.25, 341–390 (2005).
   PubMed Web of Science ®Google Scholar
• Shore B, Shore V. Heterogeneity in protein subunits of human serum high-density lipoproteins. Biochemistry7(8), 2773–2777 (1968).
   PubMedGoogle Scholar
• Gustafson A, Alaupovic P, Furman RH. Studies of the composition and structure of serum lipoproteins: isolation, purification, and characterization of very low density lipoproteins of human serum. Biochemistry4, 596–605 (1965).
   PubMed Web of Science ®Google Scholar
• Emes AV, Latner AL, Rahbani-Nobar M, Tan BH. The separation of plasma lipoproteins using gel electrofocusing and polyacrylamide gradient gel electrophoresis. Clin. Chim. Acta71(2), 293–301 (1976).
   PubMedGoogle Scholar
• Rerabek JE. Two-dimensional immunoelectrophrophoretic pattern of low- and very-low-density lipoproteins, with particular reference to Fredrickson’s type III. Clin. Chem.23(2 Pt 1), 186–194 (1977).
   PubMedGoogle Scholar
• Borresen AL, Berg K. The apoE polymorphism studied by two-dimensional, high-resolution gel electrophoresis of serum. Clin. Genet.20(6), 438–448 (1981).
   PubMedGoogle Scholar
• Zannis VI, Breslow JL. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry20(4), 1033–1041 (1981).
   PubMed Web of Science ®Google Scholar
• Rashid KA, Hevi S, Chen Y, Le Caherec F, Chuck SL. A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B. J. Biol. Chem.277(24), 22010–22017 (2002).
   PubMedGoogle Scholar
• Linnik KM, Herscovitz H. Multiple molecular chaperones interact with apolipoprotein B during its maturation. The network of endoplasmic reticulum-resident chaperones (ERp72, GRP94, calreticulin, and BiP) interacts with apolipoprotein b regardless of its lipidation state. J. Biol. Chem.273(33), 21368–21373 (1998).
   PubMedGoogle Scholar
• Hevi S, Chuck SL. Ferritins can regulate the secretion of apolipoprotein B. J. Biol. Chem.278(34), 31924–31929 (2003).
   PubMedGoogle Scholar
• Seki T, Kunichika T, Watanabe K, Orino K. Apolipoprotein B binds ferritin by hemin-mediated binding: evidence of direct binding of apolipoprotein B and ferritin to hemin. Biometals21(1), 61–69 (2007).
   PubMedGoogle Scholar
• Wang H, Gilham D, Lehner R. Proteomic and lipid characterization of apolipoprotein B-free luminal lipid droplets from mouse liver microsomes: implications for very-low density lipoprotein assembly. J. Biol. Chem.282(45), 33218–33226 (2007).
   PubMed Web of Science ®Google Scholar
• Kulinski A, Rustaeus S, Vance JE. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. J. Biol. Chem.277(35), 31516–31525 (2002).
   PubMed Web of Science ®Google Scholar
• Bondarenko PV, Cockrill SL, Watkins LK, Cruzado ID, Macfarlane RD. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J. Lipid Res.40(3), 543–555 (1999).
   PubMed Web of Science ®Google Scholar
• Mancone C, Amicone L, Fimia GM et al. Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics7(1), 143–154 (2007).
   PubMedGoogle Scholar
• Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature422(6927), 83–87 (2003).
   PubMed Web of Science ®Google Scholar
• Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science309(5733), 469–472 (2005).
   PubMed Web of Science ®Google Scholar
• Vaisar T, Pennathur S, Green PS et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest.117(3), 746–756 (2007).
   PubMed Web of Science ®Google Scholar
• Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics5(2), 551–565 (2005).
   PubMed Web of Science ®Google Scholar
• Karlsson H, Lindqvist H, Tagesson C, Lindahl M. Characterization of apolipoprotein M isoforms in low-density lipoprotein. J. Proteome Res.5(10), 2685–2690 (2006).
   PubMedGoogle Scholar
• Davidsson P, Hulthe J, Fagerberg B et al. A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes. J. Lipid Res.46(9), 1999–2006 (2005).
   PubMed Web of Science ®Google Scholar
• Hallberg C, Haden M, Bergstrom M et al. Lipoprotein fractionation in deuterium oxide gradients: a procedure for evaluation of antioxidant binding and susceptibility to oxidation. J. Lipid Res.35(1), 1–9 (1994).
   PubMedGoogle Scholar
• Stahlman M, Davidsson P, Kanmert I et al. M, Davidsson P, Kanmert I Proteomics and lipid composition of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr. J. Lipid Res.49(2), 481–490 (2007) .
   PubMedGoogle Scholar
• Hurt-Camejo E, Camejo G, Rosengren B et al. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J. Lipid Res.31(8), 1387–1398 (1990).
   PubMed Web of Science ®Google Scholar
• Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol.15(5), 551–561 (1995).
   PubMed Web of Science ®Google Scholar
• Onat A, Hergenc G, Sansoy V et al. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis168(1), 81–89 (2003).
   PubMed Web of Science ®Google Scholar
• Sacks FM, Alaupovic P, Moye LA et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation102(16), 1886–1892 (2000).
   PubMed Web of Science ®Google Scholar
• Bondarenko PV, Farwig ZN, McNeal CJ, Macfarlane RD. MALDI- and ESI-MS of the HDL apolipoproteins; new isoforms of apoA-I, II. Int. J. Mass Spectrom.219, 671–680 (2002).
   Google Scholar
• Farwig ZN, Campbell AV, Macfarlane RD. Analysis of high-density lipoprotein apolipoproteins recovered from specific immobilized pH gradient gel pI domains by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Anal. Chem.75(15), 3823–3830 (2003).
   PubMedGoogle Scholar
• Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics5(5), 1431–1445 (2005).
   PubMed Web of Science ®Google Scholar
• Rezaee F, Casetta B, Levels JH, Speijer D, Meijers JC. Proteomic analysis of high-density lipoprotein. Proteomics6(2), 721–730 (2006).
   PubMed Web of Science ®Google Scholar
• Hortin GL, Shen RF, Martin BM, Remaley AT. Diverse range of small peptides associated with high-density lipoprotein. Biochem. Biophys. Res. Commun.340(3), 909–915 (2006).
   PubMed Web of Science ®Google Scholar
• Levels JH, Bleijlevens B, Rezaee F, Aerts JM, Meijers JC. SELDI-TOF mass spectrometry of high-density lipoprotein. Proteome Sci.5, 15 (2007).
   PubMedGoogle Scholar
• Heller M, Schlappritzi E, Stalder D, Nuoffer JM, Haeberli A. Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring. Mol. Cell. Proteomics6(6), 1059–1072 (2007).
   PubMedGoogle Scholar
• Ishihama Y, Oda Y, Tabata T et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics4(9), 1265–1272 (2005).
   PubMed Web of Science ®Google Scholar
• Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest.75(2), 384–390 (1985).
   PubMed Web of Science ®Google Scholar
• Miller YI, Smith A, Morgan WT, Shaklai N. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. Biochemistry35(40), 13112–13117 (1996).
   PubMed Web of Science ®Google Scholar
• Berliner JA, Watson AD. A role for oxidized phospholipids in atherosclerosis. N. Engl. J. Med.353(1), 9–11 (2005).
   PubMed Web of Science ®Google Scholar
• Colles SM, Maxson JM, Carlson SG, Chisolm GM. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc. Med.11(3–4), 131–138 (2001).
   PubMed Web of Science ®Google Scholar
• Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis3(2), 149–159 (1983).
   PubMedGoogle Scholar
• Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis6(5), 505–510 (1986).
   PubMedGoogle Scholar
• Kang JH, Kim HT, Choi MS et al. Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics6(4), 1261–1273 (2006).
   PubMed Web of Science ®Google Scholar
• Conway JP, Kinter M. Proteomic and transcriptomic analyses of macrophages with an increased resistance to oxidized low density lipoprotein (oxLDL)-induced cytotoxicity generated by chronic exposure to oxLDL. Mol. Cell. Proteomics4(10), 1522–1540 (2005).
   PubMedGoogle Scholar
• Kinumi T, Ogawa Y, Kimata J et al. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic. Res.39(12), 1335–1344 (2005).
   PubMed Web of Science ®Google Scholar
• Chen CY, Lee CM, Hsu HC et al. Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell. Life Sci.80(26), 2469–2480 (2007).
   PubMed Web of Science ®Google Scholar
• Martinez LO, Jacquet S, Esteve JP et al. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature421(6918), 75–79 (2003).
   PubMed Web of Science ®Google Scholar
• Sukhanov S, Delafontaine P. Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells. Proteomics5(5), 1274–1280 (2005).
   PubMed Web of Science ®Google Scholar
• Drover VA, Ajmal M, Nassir F et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J. Clin. Invest.115(5), 1290–1297 (2005).
   PubMed Web of Science ®Google Scholar
• Podrez EA, Byzova TV, Febbraio M et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat. Med.13(9), 1086–1095 (2007).
   PubMed Web of Science ®Google Scholar
• van Leuven SI, Hezemans R, Levels JH et al. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn’s disease. J. Lipid Res.48(12), 2640–2646 (2007).
   PubMed Web of Science ®Google Scholar
• Han X, Gross RW. Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes. Expert Rev. Proteomics2(2), 253–264 (2005).
   PubMed Web of Science ®Google Scholar
• Watson AD. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J. Lipid Res.47(10), 2101–2111 (2006).
   PubMed Web of Science ®Google Scholar